Polycythaemia Vera — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Polycythaemia vera
Erythrocytosis with suppressed EPO, leucocytosis, and thrombocytosis is highly suggestive of polycythaemia vera (PV). JAK2 V617F mutation is positive in ~95% of PV cases. A bone marrow biopsy with JAK2 testing should be performed. Management includes phlebotomy (target haematocrit <0.45), low-dose aspirin, and cytoreductive therapy (hydroxyurea) for high-risk patients (age >60 or prior thrombosis).
Reference: eTG – 2025 – Haematology; WHO – 2022 – MPN Classification